Neoplasms, Experimental
Showing 1 - 25 of >10,000
Gastric Cancer, Healthy Trial in Hangzhou (No intervention)
Recruiting
- Gastric Cancer
- Healthy
- No intervention
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Aug 7, 2023
HPV, Related Malignancy, Related Carcinoma Trial in Houston (Experimental arm 1, Experimental arm 2, Experimental arm 3)
Recruiting
- HPV
- +2 more
- Experimental arm 1
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Breast Cancer, Liver Metastases Trial in Leuven
Not yet recruiting
- Breast Cancer
- Liver Metastases
-
Leuven, BelgiumSophia Leduc
Jan 31, 2023
Tumor Malignant, Tumor, Experimental, Solid Tumor, Adult Trial in Taipei (JS014, Interleukin 21 and humanized anti-human serum
Active, not recruiting
- Neoplasm Malignant
- +3 more
- JS014, Interleukin 21 and humanized anti-human serum albumin VHH antibody
- Pembrolizumab - anti-PD-1 antibody
-
Taipei, TaiwanWanfang Hospital -Taipei Medical University
Mar 16, 2022
Early Palliative Care in Pancreatic Cancer -Quasi-experimental
Active, not recruiting
- Pancreatic Cancer
- Palliative care
-
Frederikssund, DenmarkNordsjaellands Hospital
Nov 3, 2022
Esophageal Cancer Associated Neoantigens
Not yet recruiting
- Esophageal Cancer
- Neoantigen
- ratio of predicted neoantigens
-
Ho Chi Minh City, VietnamUniversity Medical Center Ho Chi Minh City
Aug 9, 2022
Gastric Cancer Associated Neoantigens
Not yet recruiting
- Gastric Cancer
- Neoantigens
- ratio of predicted neoantigens
-
Ho Chi Minh City, VietnamUniversity Medical Center Ho Chi Minh City
Aug 9, 2022
Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,
Not yet recruiting
- Metastatic Gastric Adenocarcinoma
- +2 more
- nal-IRI /Experimental
- +2 more
- (no location specified)
Jun 25, 2023
Lymph Node Metastasis, Cancer of Rectum and Anus, Oxaliplatin Trial in Beijing (Experimental: FOLFOXIRI and Lateral lymph node
Enrolling by invitation
- Lymph Node Metastasis
- +6 more
- Experimental: FOLFOXIRI and Lateral lymph node dissection
- Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences, Peking Uni
Sep 15, 2023
Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Tumors Trial in Guangzhou (JYP0322)
Recruiting
- Protein Kinase Inhibitors
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Nov 9, 2023
Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation
- Melanoma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 6, 2023
Malignant Tumor Trial (Experimental: DaRT seeds)
Not yet recruiting
- Malignant Tumor
- Experimental: DaRT seeds
- (no location specified)
Mar 27, 2023
Head Neck Cancer Trial in Tilburg (Experimental Intervention)
Recruiting
- Head and Neck Cancer
- Experimental Intervention
-
Tilburg, Noord Brabant, NetherlandsInstituut Verbeeten
Aug 3, 2023
Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Female Trial (Control Arm ACSM Guidelines, Experimental Arm 6-12-25
Not yet recruiting
- Breast Cancer
- +2 more
- Control Arm ACSM Guidelines
- Experimental Arm 6-12-25 repetitions per set
- (no location specified)
Nov 6, 2023
Gastric Cancer Trial in Seoul (Arm I : Experimental (Prucalopride succinate group), Arm II : Control (Mosapride citrate group))
Completed
- Gastric Cancer
- Arm I : Experimental (Prucalopride succinate group)
- Arm II : Control (Mosapride citrate group)
-
Seoul, Korea, Republic ofGangnamSeverance Hospital
Jul 21, 2023
Colon Cancer Trial in Málaga (Experimental Treatment, DCOOP Product, Hydroxytyrosol extract, Experimental Treatment,Indukern
Not yet recruiting
- Colon Cancer
- Experimental Treatment, DCOOP Product, Hydroxytyrosol extract
- +2 more
-
Málaga, SpainHospital Regional Universitario de Málaga
Jul 21, 2022
Colorectal Cancer, Monkey Pox Trial in Nanning (Immunohistochemical staining with anti-FOS)
Recruiting
- Colorectal Cancer
- Monkey Pox
- Immunohistochemical staining with anti-FOS
-
Nanning, Guangxi, ChinaGuangxi Medical University Cancer Hospital
Jan 25, 2023
Small Cell Lung Cancer Trial in Hangzhou (1.Experimental: A (Part 1): Fluzoparib and SHR -1316, 2.Experimental: B (Part 1):
Completed
- Small Cell Lung Cancer
- 1.Experimental: A (Part 1): Fluzoparib and SHR -1316
- +2 more
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Jun 16, 2022
Colorectal Cancer, Gastrointestinal Dysfunction Trial in Shanghai (Electroacupuncture group, Sham EA group)
Not yet recruiting
- Colorectal Cancer
- Gastrointestinal Dysfunction
- Electroacupuncture group
- Sham EA group
-
Shanghai, Shanghai, ChinaShanghai Yueyang Integrated Medicine Hospital
Nov 10, 2023
Oncology Trial in Los Altos
Recruiting
- Oncology
-
Los Altos, CaliforniaCancer Commons
Jan 31, 2023
Multiple Myeloma, Primary Plasma Cell Leukemia Trial in Shanghai (Experimental: CAR-T cells Infusion)
Not yet recruiting
- Multiple Myeloma
- Primary Plasma Cell Leukemia
- Experimental: CAR-T cells Infusion
-
Shanghai, ChinaShanghai Changzheng Hospital
Apr 20, 2023
Hematologic Cancer Trial (experimental:Acute leukemia/myelodysplastic or myeloproliferative disease)
Not yet recruiting
- Hematologic Cancer
- experimental:Acute leukemia/myelodysplastic or myeloproliferative disease
- (no location specified)
Oct 26, 2022
Breast Cancer Trial in Nice (Metal wire, Radioactive Iodine Seed)
Active, not recruiting
- Breast Cancer
- Metal wire
- Radioactive Iodine Seed
-
Nice, FranceCentre Antoine LACASSAGNE
Jan 19, 2023
NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,
Not yet recruiting
- Non-small Cell Lung Cancer
- Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
- placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
-
Tianjing, Tianjin, ChinaTianjin cancer hospital
Nov 3, 2023